Keyword: Ligand Pharmaceuticals


Ligand Pharmaceuticals to Acquire Apeiron Biologics for €92 Million

09.07.2024 -

Ligand Pharmaceuticals recently announced that it has entered into a definitive agreement to acquire Apeiron Biologics AG, which holds royalty rights to Qarziba...

Strategy & Management

Devalued and Distrusted

08.05.2014 - A Pharma Veteran's View - Dr. John L. LaMattina is the former Senior Vice President of Pfizer, and President, Pfizer Global Research and Development. In this role, Dr. LaMattina...